Africa’s malaria experts have convened in the Tanzanian capital Dar-es-Salaam for the National Malaria Control Programme (NMCP) Best Practice Sharing Workshop.
The gathering, now in its 13th edition, provides a platform to discuss and share knowledge and experiences, and drive dialogue around improved health outcomes and access to quality antimalarial treatments for patients in Africa.
The event is being hosted by Novartis, in association with the Global Fund, World Health Organisation (WHO), the WorldWide Antimalarial Resistance Network, the Kenya Medical Research Institute-Wellcome Trust, Swiss Tropical and Public Health Institute, US Pharmacopeia, Populations Services International, Ifakara Health Institute, and the Pharmacy and Poisons Board.
“These NMCP meetings have led to groundbreaking projects such as the development of SMS for Life to improve antimalarial stock management in rural health facilities,” Dr Linus Igwemezie, head of the Novartis Malaria Initiative, said in a statement.
“We believe that by bringing together the best minds and leaders in the field, we can help foster new approaches that will help us ensure all patients have access to quality antimalarials and bring us closer to malaria elimination.”
The successful treatment of malaria depends on the public being informed about the risks of the disease, the importance of sleeping under insecticide treated bednets, and having access to health services, including appropriate diagnostic tests and quality-assured antimalarial treatments.
Malaria, a mosquito-borne disease, killed more than 627 000 adults and 483 000 children globally in 2012, WHO said in its factsheet malaria report.